Disconnected systems – not a lack of technology – are slowing clinical trial execution and forcing site staff to bridge costly workflow gaps.
- Clinical Research Isn't Even A Recognized Job. That's A Problem.
- What Will Life Science Orgs Do When The AI Bill Comes Through?
- Clinical Trial Standards — What They Are And Why They're Indispensable
- The Data Was Already There: RWE's Real Bottleneck Is People
- Two Planning Mistakes That Quietly Sink Clinical Programs
- Duplicate Tech, Not Technology, Is Burning Out Trial Sites
- The Real Reason Clinical Trial Systems Don't Talk To Each Other
- The Vendor Questions Most Clinical Tech Buyers Forget To Ask
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Fujirebio Increases Study Agility By Streamlining Clinical Operations And Data Management Process
Fujirebio’s fast-growing U.S. Clinical R&D team was preparing for shorter studies with higher complexity. Traditional methods using paper and spreadsheet trackers were no longer adequate to meet quality goals. Learn how the group increased its agility and readiness with LifeSphere Clinical EDC and CTMS tools.
-
Wearable DHT 101: Foundations For Use In Regulated Clinical Trials
Delve into the benefits of continuous sensor data, the scope of wearable use in clinical trials, and the specific sensors and measures employed by wearable DHTs.
-
5 Features to Look for in Your Next eTMF
Not every electronic trial master file will provide the robust support and compliance measures required. When searching for a successful solution, make sure the eTMF of interest has these five features.
-
How Vanguard Clinical Harnesses CDMS/EDC For Faster Results
Uncover how this CRO was able to stay agile by choosing a CDMS/EDC partner that prioritized sponsor needs and streamlined operations to achieve top-tier results swiftly.
-
Fast Data Insights Improve Productivity, Client Centricity
Discover how Medidata's Rave CTMS seamlessly met the comprehensive requirements of Catalyst Clinical Research—an exclusive CRO provider specializing in oncology—during a period of rapid expansion.
-
How Pfizer Used Wearable DHTs To Reveal Meaningful Treatment Effects In Cancer Cachexia
Wearable digital health technologies (DHTs) played a crucial role in assessing patient-centric outcomes during pfizer's study into the benefits of using ponsegromab for treating cancer cachexia.
-
Patient-Centric Clinical Trials: The Power Of Choice
Patient-centric trials, advocated by the FDA, focus on offering choices to improve engagement, diversity, and data quality. Explore how expanding patient choice can benefit clinical trials.
-
How Can Sponsors Enable Research-Naïve Clinical Trial Sites
Clinical trial capacity in the U.S. is heavily concentrated, and technology is playing a critical role in enabling a shift to expanding site networks and alleviating the burden on sites and patients.
-
CRO Uses CRIO eSource To Double Monitoring Productivity
Examine the transformative impact of eSource technology on monitoring productivity during a global Phase 3 trial conducted by a Contract Research Organization (CRO) amid the COVID-19 pandemic.
-
5 Ways Lab Data Can Help Commercialize Your Therapy
Delve into five pivotal insights for leveraging lab data effectively and the collaboration that accelerated market entry for new therapies while ensuring the needs of targeted populations were met.
- Clinical Trial Sites Don't Need More Tech, They Need Fewer Silos
- A Biostatistician's Caution Around Digital Twins In Trials
- Who Owns Data Quality? The Authority Gap Slowing Trials
- Clinical Research Isn't Even A Recognized Job. That's A Problem.
- The Data Was Already There: RWE's Real Bottleneck Is People
RECENT NEWSLETTERS
- 09.10.26 -- AI, Trial Costs, And RTSM Are Reshaping Clinical Operations
- 09.05.26 -- Best Of August: AI, FDA RWE, And Trial Data Risks
- 09.03.26 -- AI, APIs, and eConsent Are Exposing Trial Workflow Gaps
- 08.27.26 -- Patient Data Breaks Down When Trial Systems Miss Reality
- 08.20.26 -- Clinical AI Validation, Trial Handoffs, And Smarter Study Builds